The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
Open accessAbstract
Upon activation, brain microglial cells release proinflammatory mediators, such as TNFα, which may play an important role in eliciting neuroinflammatory processes causing brain damage. As cannabinoids have been reported to exert anti‐inflammatory and neuroprotective actions in the brain, we here examined the effect of both synthetic and endogenous cannabinoids on TNFα release elicited by bacterial endotoxin lypopolysaccharide (LPS) in cultured microglia. Exposure of primary cultures of rat cortical microglial cells to LPS significantly stimulated TNFα mRNA expression and release. The endogenous cannabinoids anandamide and 2‐arachidonylglycerol (2‐AG), as well as the synthetic cannabinoids (+)WIN 55,212‐2, CP 55,940, and HU210, inhibited in a concentration‐dependent manner (1–10 μM) the LPS‐induced TNFα release. Unlike the high‐affinity cannabinoid receptor agonist (+)WIN 55,212‐2, the low‐affinity stereoisomer (−)WIN 55,212‐2 did not exert any significant inhibition on TNFα release. Given this stereoselectivity, the ability of (+)WIN 55,212‐2 to inhibit LPS‐induced TNFα release from microglia is most likely receptor‐mediated. By RT‐PCR we found that the two G i/o protein‐coupled cannabinoid receptors (type 1 and 2) are both expressed in microglial cultures. However, selective antagonists of type 1 (SR141716A and AM251) and type 2 (SR144528) cannabinoid receptors did not affect the effect of (+)WIN 55,212‐2. Consistent with this finding is the observation that the ablative effect of (+)WIN 55,212‐2 on LPS‐evoked release of TNFα was not sensitive to the G i/o protein inactivator pertussis toxin. In addition, the cAMP elevating agents dibutyryl cAMP and forskolin both abolished LPS‐induced TNFα release, thus rendering unlikely the possibility that (+)WIN 55,212‐2 could ablate TNFα release through the inhibition of adenylate cyclase via the G i‐coupled cannabinoid receptors type 1 and 2. In summary, our data indicate that both synthetic and endogenous cannabinoids inhibit LPS‐induced release of TNFα from microglial cells. By showing that such effect does not appear to be mediated by either CB receptor type 1 or 2, we provide evidence suggestive of the existence of yet unidentified cannabinoid receptor(s) in brain microglia. GLIA 41:161–168, 2003. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Microglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,119
Cytokines in inflammatory brain lesions: helpful and harmful
Merrill, J. E., & Benveniste, E. N. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10047-3 · Cited by 722
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
Glass, M., & Felder, C. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 635
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 541
Shohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben-Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 337
Felder, C. C., Veluz, J. S., Williams, H. L., Briley, E. M., & Matsuda, L. A. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09174-6 · Cited by 261
Gatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00279-8 · Cited by 252
Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
Puffenbarger, R. A., Boothe, A. C., & Cabral, G. A. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<58::aid-glia6>3.0.co;2-w · Cited by 248
Molecular mechanisms of microglial activation
Zielasek, J., & Hartung, H.-P. (1996) · Advances in Neuroimmunology · doi:10.1016/0960-5428(96)00017-4 · Cited by 244
Haslam, R. J., Davidson, M. M. L., & Desjardins, J. V. (1978) · Biochemical Journal · doi:10.1042/bj1760083 · Cited by 238
Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38093-0 · Cited by 222
The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling
Bayewitch, M., Avidor-Reiss, T., Levy, R., Barg, J., Mechoulam, R., & Vogel, Z. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01207-u · Cited by 210
Heneka, M. T., Löschmann, P., Gleichmann, M., Weller, M., Schulz, J. B., Wüllner, U., & Klockgether, T. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010088.x · Cited by 199
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders
De Petrocellis, L., Melck, D., Bisogno, T., & Di Marzo, V. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00196-1 · Cited by 173
Gallily, R., Breuer, A., & Mechoulam, R. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00653-1 · Cited by 163
Levi, G., Patrizio, M., Bernardo, A., Petrucci, T. C., & Agresti, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1541 · Cited by 148
Anandamide suppresses nitric oxide and TNF-α responses to Theilerʼs virus or endotoxin in astrocytes
Molina‐Holgado, F., Lledó, A., & Guaza, C. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00027 · Cited by 110
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
Calandra, B., Portier, M., Kernéis, A., Delpech, M., Carillon, C., Fur, G. L., Ferrara, P., & Shire, D. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00349-0 · Cited by 108
Sánchez, C., Rueda, D., Ségui, B., Galve‐Roperh, I., Levade, T., & Guzmán, M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.955 · Cited by 102
Rinaldi, M. L., Duigou, A. L., Oustric, D., Barth, F., Bouaboula, M., Carayon, P., Casellas, P., & Fur, G. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37898-x · Cited by 98
Sagan, S., Venance, L., Torrens, Y., Cordier, J., Glowinski, J., & Giaume, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00480.x · Cited by 90
Achiron, A., Miron, S., Lavie, V., Margalit, R., & Biegon, A. R. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00149-6 · Cited by 77
Cannabinoid Receptors and Their Endogenous Agonist, Anandamide
Axelrod, J., & Felder, C. C. (1998) · Neurochemical Research · doi:10.1023/a:1022418217479 · Cited by 72
Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia
Leker, R. R., Shohami, E., Abramsky, O., & Ovadia, H. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00301-3 · Cited by 63
Venters, H., Dantzer, R., & Kelley, K. W. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05385.x · Cited by 62
Sinha, D., Bonner, T. I., Bhat, N. R., & Matsuda, L. A. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00181-1 · Cited by 55
Kaminski, N. E. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00284-7 · Cited by 31
Cited by
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & de Ceballos, M. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Neurotransmitter receptors on microglia
Pocock, J. M., & Kettenmann, H. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.007 · Cited by 650
Pharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Metadata
- Authors
- Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M., & Leon, A.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2002-12-28
- Volume
- 41
- Issue
- 2
- Pages
- 161-168
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2077344563
- Cited by
- 275
- References
- 31
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.